Berner-Wygoda Y, Li M, Perlon C, Malon D, et al. Safety and Effectiveness of Adriamycin and Cyclophosphamide Followed by Dose Dense (Every 2 Weeks) Paclitaxel Given With Trastuzumab as Neoadjuvant Treatment in HER2-Positive Early-Stage Breast Cancer. Clin Breast Cancer 2025 Apr 28:S1526-8209(25)00108.
PMID: 40399223